Article Archives - Page 32 of 50

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

Article September 14, 2017

Key Messages This editorial examined genetic variation in the D2 dopamine receptor system and the implications for treatment of neuropsychiatric disease. The most commonly studied variant in published in vivo… Read More

Ten-Year Outcomes Of First-Episode Psychoses In The MRC ÆSOP-10 Study

Article September 14, 2017

Key Messages This study examined clinical and social outcomes, and mortality rates for a 10-year period in a cohort of patients with first-episode psychosis. While clinical course had a large… Read More

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

Article September 14, 2017

Key Messages This review explored potential mechanisms linking circadian and sleep abnormalities in schizophrenia and psychosis, with a particular focus on dopaminergic pathways. Sleep disruption and circadian rhythm disturbance may… Read More

Webinar Summary – Suicide Affects Everyone: The Role Of The Health Care Professional In Suicide Prevention

Article September 14, 2017

This summary was developed utilizing the full recorded presentation of this webinar. You can access the full sourcing, polling results, or recording here: https://psychu.org/suicide-affects-everyone-role-health-care-professional-suicide-prevention/. On September 14, 2017, internationally recognized… Read More

Suicide Risk Screening In Health Care Settings: Identifying Males & Females At Risk

Article September 13, 2017

Key Messages More males than females die from suicide, but females are more likely to consider or think about suicide. The Joint Commission has established suicide risk screening requirements for… Read More

Coping Strategies & Self-Stigma In Patients With Schizophrenia-Spectrum Disorders

Article September 11, 2017

Key Messages This study explored the relationship between self-stigma, coping strategies, and subjective assessment of psychopathology in patients with schizophrenia-spectrum disorders. Compared with the general population, patients with schizophrenia-spectrum disorders… Read More

Article

Genetic Variation & The D2 Dopamine Receptor: Implications For The Treatment Of Neuropsychiatric Disease

Ten-Year Outcomes Of First-Episode Psychoses In The MRC ÆSOP-10 Study

Schizophrenia: The Role Of Sleep & Circadian Rhythms In Regulating Dopamine & Psychosis

Webinar Summary – Suicide Affects Everyone: The Role Of The Health Care Professional In Suicide Prevention

Suicide Risk Screening In Health Care Settings: Identifying Males & Females At Risk

Coping Strategies & Self-Stigma In Patients With Schizophrenia-Spectrum Disorders

The Neurobiology Of Motivational Deficits In Depression – An Update On Candidate Pathomechanisms

Anxiety Symptoms In A Major Mood & Schizophrenia Spectrum Disorders

Training To Enhance Psychiatrist Communication With Patients With Psychosis (TEMPO): Cluster Randomised Controlled Trial

Treatment Patterns For Major Depressive Disorder: What Happens After The First Antidepressant Is Prescribed?

Now Leaving PsychU

This link will take you outside of the PsychU community website

PsychU

Sorry, this content is no longer available.

Stay Connected: